DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for ...
MedPage Today on MSN
Novel Rapid-Acting Drug Proves Effective in Severe PTSD
Results support the neuroplastogen as a "potential acute, intermittent" therapy, researche ...
Optimi holds a Medication Establishment Licence issued by Health Canada that authorises the manufacture of the MD-MA capsules for regulated therapeutic use, including the treatment of Post-Traumatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results